Yes. Remote consultations using Dexcom Clarity may still be eligible for reimbursement under billing code 95251. For resources to set up Dexcom Clarity Clinic, please click here.

*The reimbursement information provided is intended to assist you with billing for your services related to continuous glucose monitoring (CGM). It is intended for informational purposes only and is not a guarantee of coverage and payment. Providers are encouraged to contact their local payers with questions related to coverage, coding, and payment.

Yes. Dexcom apps and software will continue to operate without interruption, and the company does not anticipate any outages or delays due to the coronavirus situation. Patients may check the live status of each of our apps and software at status.dexcom.com.

Please click here for patient support and resources.

Dexcom will continue to process re-orders, but we ask that patients only contact the Customer Sales Support and Technical Support teams at 844-607-8398 with urgent requests at this time.

Answers to many common patient questions are available at dexcom.com/answers, and patients can submit web self-service tickets at dexcom.com/contact. Our team will work to expeditiously respond to those inquiries.

The Dexcom CARE team is also still available at dexcom.com/dexcom-care or 877-339-2664 to help patients that are new to Dexcom and need help getting started with their product.

Patients can continue to get their products from the pharmacy or DME providers. Several national pharmacies are offering home delivery services. Please ask your patients to contact their preferred pharmacy or DME provider for options.

A glucometer measures the sugar levels in a patient's blood, while a Continuous Glucose Monitor (CGM) monitors the levels in interstitial fluid, the fluid between cells in your tissues. Traditional glucometers require a consistent supply of test strips for use, whereas Dexcom is an unblinded non-adjunctive CGM.  The traditional method for patients of measuring glucose levels requires a fingerstick using a glucometer (blood glucose meter) which provides a glucose reading at a single point in time. The key difference between Dexcom CGM and a glucometer is that Dexcom CGM provides glucose readings throughout the day and night, including glucose speed and direction arrows that empower wearers with more information for more informed decision making•. Finally, Dexcom CGM is designed with alerts to warn the wearer of glucose highs and lows during critical times like playing, sleeping, or exercising to help wearers catch high and lows before they become critical.  Here is an example of how Dexcom CGM information could impact glucose management decisions:  Glucometer (BGM) READING: 119 

CONTINUOUS GLUCOSE MONITOR (CGM) READING: 119 

*smart devices sold separately. 
(The straight down arrow signal a rapid decline in glucose) 

Comparing cgm vs glucometer accuracy, both provided patients with current and accurate glucose readings. However, based on the Glucometer (BGM) reading of 119, this person is likely to decide that no action is required. But, with a similar glucose level reading on the Dexcom CGM and the straight down arrow, the patient might decide to eat some carbohydrates to avoid having a hypoglycemic event. 

A continuous glucose monitor (CGM) is an FDA-­approved device that provides continuous insight into glucose levels throughout the day and night. CGM also displays information about glucose direction and speed giving users additional information to help with their diabetes management. CGM also provides customizable alerts to warn the wearer of approaching glucose highs and lows. Studies have shown that CGM contributes to a decrease in HbA1c without increasing the risk for hypoglycemia.¹

CPE/CME courses are available for credit at cgmeducation.net. All courses are free online and available on demand.

If you have questions about Clarity, please contact the Dexcom Care Team at [email protected] or call 1-888-738-3646, option 4.

For every release, a notification banner is posted at the top of the Dexcom Clarity on the day of the release. Follow the banner’s link to read the release notes. If the Uploader software is updated, the notification banner posts 2 weeks before the release.

Glucose Management Indicator (GMI) approximates the laboratory A1C level expected based on average glucose measured using continuous glucose monitoring (CGM) values. Average glucose is derived from at least 12 days of CGM data. The GMI may be similar to, higher than, or lower than the laboratory A1C. Differences between GMI and laboratory A1C may reflect differences among an individual’s red blood cell lifespan, how glucose binds to hemoglobin, or due to a recent fluctuation in glucose control.

GMI Calculation: How is Glucose Management Indicator Calculated?

In order to determine a GMI calculation, it is necessary to compute the average glucose level and transform it from milligrams per deciliter (mg/dL) to a percentage.

The formula for calculating the GMI as a percentage is: GMI (Percentage) = 3.31 + 0.02392 x (glucose reading in mg/dL).